Literature DB >> 16135000

Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells.

P Salamon1, N G Shoham, R Gavrieli, B Wolach, Y A Mekori.   

Abstract

BACKGROUND: Mast cells have recently been shown to control neutrophil recruitment during T-cell mediated cutaneous DTH reaction in vivo through TNF-alpha and MIP-2, the functional murine analogue of human IL-8. Although the nature of signals transmitted from T cells which activate mast cells has not yet been defined, we hypothesized that a direct cross-talk (i.e. heterotypic adhesion) between these two cell populations exists, as has previously been reported. AIMS: The present study was aimed at gaining insight into the functional role of mast cell-T cell contact in expression and release of IL-8, and its effect on neutrophil chemotaxis.
METHODS: The IL-8 gene expression was identified by Affymetrix GeneChip arrays, validated by RT-PCR and the protein measured by ELISA. Chemotaxis was evaluated by using a modified Boyden chamber assay.
RESULTS: Mast cells were found to express and release significantly higher concentrations of IL-8 on incubation with membranes obtained from activated, as compared to resting T cells. Supernatants obtained from these activated mast cells induced significant neutrophil chemotaxis that was inhibited by neutralizing mAb to IL-8.
CONCLUSIONS: Thus, activated T cells, on heterotypic adhesion to mast cells, deliver the necessary signals for the latter to release cytokines and chemokines necessary for cell migration to sites of antigen challenge, thereby facilitating T-cell mediated inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135000     DOI: 10.1111/j.1398-9995.2005.00886.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  23 in total

1.  Characterization of ERK activation in human mast cells stimulated by contact with T cells.

Authors:  Adam Mor; Irit Shefler; Pazit Salamon; Yoel Kloog; Yoseph A Mekori
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

2.  Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.

Authors:  D Kempuraj; M Tagen; B P Iliopoulou; A Clemons; M Vasiadi; W Boucher; M House; A Wolfberg; T C Theoharides
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

3.  The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.

Authors:  Zuyi Weng; Arti B Patel; Smaro Panagiotidou; Theoharis C Theoharides
Journal:  J Allergy Clin Immunol       Date:  2014-12-10       Impact factor: 10.793

Review 4.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

Review 5.  Pharmacotherapy of systemic sclerosis.

Authors:  Arnold E Postlethwaite; L Jeff Harris; Syed H Raza; Swapna Kodura; Titilola Akhigbe
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

6.  SNAP23-Dependent Surface Translocation of Leukotriene B4 (LTB4) Receptor 1 Is Essential for NOX2-Mediated Exocytotic Degranulation in Human Mast Cells Induced by Trichomonas vaginalis-Secreted LTB4.

Authors:  Arim Min; Young Ah Lee; Kyeong Ah Kim; Jamel El-Benna; Myeong Heon Shin
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

7.  Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.

Authors:  Marie Fischer; Ilkka T Harvima; Ricardo F S Carvalho; Christine Möller; Anita Naukkarinen; Gunilla Enblad; Gunnar Nilsson
Journal:  J Clin Invest       Date:  2006-09-07       Impact factor: 14.808

Review 8.  Mast cells and eosinophils: the two key effector cells in allergic inflammation.

Authors:  Yael Minai-Fleminger; Francesca Levi-Schaffer
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

9.  The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes.

Authors:  K Nagai; Y Takahashi; I Mikami; T Fukusima; H Oike; M Kobori
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

10.  Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.

Authors:  Zohara Sternberg; Kailash Chadha; Alicia Lieberman; Allison Drake; David Hojnacki; Bianca Weinstock-Guttman; Frederick Munschauer
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.